Voyager Therapeutics Inc VYGR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 9:00 AM EDT
8.81quote price arrow up+0.33 (+3.89%)
Volume
1,930
Close
8.48quote price arrow up+0.04 (+0.47%)
Volume
375,253
52 week range
6.06 - 14.34
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close8.48
  • 52 Week High14.34
  • 52 Week High Date05/22/23
  • 52 Week Low6.06
  • 52 Week Low Date11/13/23

Key Stats

  • Market Cap461.213M
  • Shares Out54.39M
  • 10 Day Average Volume0.47M
  • Dividend-
  • Dividend Yield-
  • Beta1.04
  • YTD % Change0.47

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close8.48
  • 52 Week High14.34
  • 52 Week High Date05/22/23
  • 52 Week Low6.06
  • 52 Week Low Date11/13/23
  • Market Cap461.213M
  • Shares Out54.39M
  • 10 Day Average Volume0.47M
  • Dividend-
  • Dividend Yield-
  • Beta1.04
  • YTD % Change0.47

RATIOS/PROFITABILITY

  • EPS (TTM)2.96
  • P/E (TTM)2.87
  • Fwd P/E (NTM)-4.43
  • EBITDA (TTM)126.455M
  • ROE (TTM)89.61%
  • Revenue (TTM)250.008M
  • Gross Margin (TTM)-
  • Net Margin (TTM)52.93%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Voyager Therapeutics Inc

 

Profile

MORE
Voyager Therapeutics, Inc. is a biotechnology company focused on advancing neurogenetic medicines. The Company’s pipeline includes programs for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple other diseases of the central nervous system. Many of its programs are derived from its TRACER AAV capsid discovery platform, which is used to generate novel capsids and identify associated receptors to potentially enable high brain penetration...
Michael Higgins
Independent Chairman of the Board
Alfred Sandrock M.D., Ph.D.
President, Chief Executive Officer, Director
Robin Swartz
Principal Financial Officer, Principal Accounting Officer
Address
75 Hayden Avenue
Lexington, MA
02421
United States